Literature DB >> 7929647

Polymorphonuclear leukocyte behavior in a nonhuman primate focal ischemia model.

J A Ember1, G J del Zoppo, E Mori, W S Thomas, B R Copeland, T E Hugli.   

Abstract

There is increasing interest in the role of polymorphonuclear (PMN) leukocytes in the evolution of focal cerebral infarction. Surgical preparation of focal cerebral ischemia models may alter leukocyte reactivity and thereby make interpretation of leukocyte function following ischemia/reperfusion difficult. The effects of surgical preparation and of experimental ischemia/reperfusion on granulocyte function have been examined prospectively in a baboon model. Twenty-six adolescent male baboons underwent surgical preparation, of which 21 underwent middle cerebral artery occlusion/reperfusion. Four additional animals served as nonsurgical controls. Peripheral venous blood specimens were taken for performing assays of leukocyte function at defined intervals before and after both the surgical preparation (i.e., the overall procedure for implantation of the middle cerebral artery occlusion device) and occlusion/reperfusion. A stress-related elevation in total leukocyte number was attributed mainly to an increase in the number of circulating PMN leukocytes. Values rose from 13.9 +/- 4.9 x 10(3) to 27.8 +/- 5.8 x 10(3)/microliters, (+/- SD; n = 21) for total leukocyte number, with p < 0.001, and from 4.3 +/- 2.1 x 10(3) to 15.9 +/- 4.7 x 10(3)/microliters (n = 21) for PMN leukocytes, with p < 0.001. Surgical preparation had no effect (p > or = 0.4) on the ability of PMN leukocytes, isolated 24 h after the implantation procedure, to display polarization, O2.- production, or beta-glucuronidase release when stimulated with human C5a. A moderate decrease in the chemotactic response to C5a resolved within the 7-day postsurgery (preocclusion) period. Three-hour middle cerebral artery occlusion and 1-h reperfusion resulted in a significant reduction in C5a-induced polarization.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929647     DOI: 10.1038/jcbfm.1994.137

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  6 in total

1.  Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke.

Authors:  Frances Rena Bahjat; Rebecca L Williams-Karnesky; Steven G Kohama; G Alexander West; Kristian P Doyle; Maxwell D Spector; Theodore R Hobbs; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-02       Impact factor: 6.200

2.  Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures.

Authors:  Klaus Dinkel; Firdaus S Dhabhar; Robert M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-18       Impact factor: 11.205

3.  Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion.

Authors:  J H Garcia; K F Liu; J K Relton
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

4.  The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury.

Authors:  C Iadecola; C A Salkowski; F Zhang; T Aber; M Nagayama; S N Vogel; M E Ross
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

5.  Periprocedural Antithrombotic Treatment During Acute Mechanical Thrombectomy for Ischemic Stroke: A Systematic Review.

Authors:  Rob A van de Graaf; Vicky Chalos; Gregory J Del Zoppo; Aad van der Lugt; Diederik W J Dippel; Bob Roozenbeek
Journal:  Front Neurol       Date:  2018-04-16       Impact factor: 4.003

6.  Combined Perfusion and Permeability Imaging Reveals Different Pathophysiologic Tissue Responses After Successful Thrombectomy.

Authors:  Arne Potreck; Matthias A Mutke; Charlotte S Weyland; Johannes A R Pfaff; Peter A Ringleb; Sibu Mundiyanapurath; Markus A Möhlenbruch; Sabine Heiland; Mirko Pham; Martin Bendszus; Angelika Hoffmann
Journal:  Transl Stroke Res       Date:  2021-01-11       Impact factor: 6.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.